Evidence map›Paper›PMID 31003566›Full record

ArticleInternational journal of molecular sciences2019

A Small In Vitro Fermentation Model for Screening the Gut Microbiota Effects of Different Fiber Preparations.

Irina Tsitko, Fanny Wiik-Miettinen, Outi Mattila, Natalia Rosa-Sibakov, Tuulikki Seppänen-Laakso, Johanna Maukonen, Emilia Nordlund, Maria Saarela

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Predicting the potential deterioration of Barrett's esophagus based on gut microbiota: a Mendelian randomization analysis.Mammalian genome : official journal of the International Mammalian Genome Society · 2024
    Article
  5. Dietary jack bean (Heliyon · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Development of anFrontiers in microbiology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Irina TsitkoVTT Technical Research Centre of Finland, Limited, Post Office Box 1000, Tietotie 2, 02044 Espoo, Finland. irina.tsitko@vtt.fi.
Fanny Wiik-MiettinenVTT Technical Research Centre of Finland, Limited, Post Office Box 1000, Tietotie 2, 02044 Espoo, Finland. fanny.wiik@helsinki.fi.
Outi MattilaVTT Technical Research Centre of Finland, Limited, Post Office Box 1000, Tietotie 2, 02044 Espoo, Finland. outi.mattila@vtt.fi.
Natalia Rosa-SibakovVTT Technical Research Centre of Finland, Limited, Post Office Box 1000, Tietotie 2, 02044 Espoo, Finland. natalia.rosa-sibakov@vtt.fi.
Tuulikki Seppänen-LaaksoVTT Technical Research Centre of Finland, Limited, Post Office Box 1000, Tietotie 2, 02044 Espoo, Finland. Tuulikki.Seppanen-Laakso@vtt.fi
Johanna MaukonenVTT Technical Research Centre of Finland, Limited, Post Office Box 1000, Tietotie 2, 02044 Espoo, Finland. pia-johanna.maukonen@dupont.com.
Emilia NordlundVTT Technical Research Centre of Finland, Limited, Post Office Box 1000, Tietotie 2, 02044 Espoo, Finland. emilia.nordlund@vtt.fi.
Maria SaarelaVTT Technical Research Centre of Finland, Limited, Post Office Box 1000, Tietotie 2, 02044 Espoo, Finland. mariahsaarela@gmail.com.
Tieto (Finland) · FIDuPont (Finland) · FI

Funding

Business Finland 1438/31/2016
6 · The paper itself

Abstract

The development of prebiotic fibers requires fast high-throughput screening of their effects on the gut microbiota. We demonstrated the applicability of a mictotiter plate in the in vitro fermentation models for the screening of potentially-prebiotic dietary fibers. The effects of seven rye bran-, oat- and linseed-derived fiber preparations on the human fecal microbiota composition and short-chain fatty acid production were studied. The model was also used to study whether fibers can alleviate the harmful effects of amoxicillin-clavulanate on the microbiota. The antibiotic induced a shift in the bacterial community in the absence of fibers by decreasing the relative amounts of Bifidobacteriaceae, Bacteroidaceae, Prevotellaceae, Lachnospiraceae and Ruminococcaceae, and increasing proteobacterial Sutterilaceae levels from 1% to 11% of the total microbiota. The fermentation of rye bran, enzymatically treated rye bran, its insoluble fraction, soluble oat fiber and a mixture of rye fiber:soluble oat fiber:linseed resulted in a significant increase in butyrate production and a bifidogenic effect in the absence of the antibiotic. These fibers were also able to counteract the negative effects of the antibiotic and prevent the decrease in the relative amount of bifidobacteria. Insoluble and soluble rye bran fractions and soluble oat fiber were the best for controlling the level of proteobacteria at the level below 2%.

Indexed as

BacteroidetesBifidobacteriumDietary FiberFatty Acids, VolatileFecesFermentationGastrointestinal MicrobiomeHumansPrebioticsProteobacteriaDietary FiberFatty Acids, VolatilePrebioticsfecal fermentationfiber preparationinulinin vitro colon modellinseedresistant starchrye bran

Identifiers

PMID31003566
PMCPMC6514940
OpenAlexW2937847545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.